These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3867344)

  • 21. Yersiniae and iron intoxication.
    Stein ZL; Barkin RL
    Drug Intell Clin Pharm; 1987; 21(7-8):661. PubMed ID: 3608819
    [No Abstract]   [Full Text] [Related]  

  • 22. Generalized infection with Yersinia enterocolitica and the role of iron.
    Robins-Browne RM; Rabson AR; Koornhof HJ
    Contrib Microbiol Immunol; 1979; 5():277-82. PubMed ID: 535384
    [No Abstract]   [Full Text] [Related]  

  • 23. Acute renal failure occurring during intravenous desferrioxamine therapy: recovery after haemodialysis.
    Cianciulli P; Sorrentino F; Forte L; Palombi M; Papa G; Meloni C; Taccone Gallucci M; Casciani CU
    Haematologica; 1992; 77(6):514-5. PubMed ID: 1289188
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Yersinia enterocolitica bacteremia in a chronically transfused patient with sickle cell anemia. Case report and review of the literature.
    Blei F; Puder DR
    Am J Pediatr Hematol Oncol; 1993 Nov; 15(4):430-4. PubMed ID: 8214368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Yersinia enterocolitica sepsis after blood transfusion.
    Hoelen DW; Tjan DH; Schouten MA; Dujardin BC; van Zanten AR
    Neth J Med; 2007 Sep; 65(8):301-3. PubMed ID: 17890790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yersinia enterocolitica and transfusion-induced septicemia.
    Brown SE; White SE
    Anesth Analg; 1988 Apr; 67(4):415-7. PubMed ID: 3354879
    [No Abstract]   [Full Text] [Related]  

  • 27. Study of intermittent intravenous deferrioxamine high-dose therapy in heavily iron-loaded children with beta-thalassemia major poorly compliant to subcutaneous injections.
    Wali YA; Taqi A; Deghaidi A
    Pediatr Hematol Oncol; 2004; 21(5):453-60. PubMed ID: 15205089
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infection with Yersinia enterocolitica in patients with iron overload.
    Chiu HY; Flynn DM; Hoffbrand AV; Politis D
    Br Med J (Clin Res Ed); 1986 Jan; 292(6513):97. PubMed ID: 3080107
    [No Abstract]   [Full Text] [Related]  

  • 29. The role of desferrioxamine in dialysis-associated mucormycosis: report of three cases and review of the literature.
    Boelaert JR; van Roost GF; Vergauwe PL; Verbanck JJ; de Vroey C; Segaert MF
    Clin Nephrol; 1988 May; 29(5):261-6. PubMed ID: 3293856
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Iron-overload in patients on maintenance hemodialysis: diagnostic criteria, indications and treatment by desferrioxamine (author's transl)].
    Simon P; Bonn F; Guezennec M; Tanquerel T; Ksang
    Nephrologie; 1981; 2(4):165-70. PubMed ID: 7329501
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Infectious risks in patients with renal failure on hemodialysis. Importance of iron overload and deferoxamine].
    Hoen B; Kessler M
    Presse Med; 1991 Apr; 20(15):681-2. PubMed ID: 1828579
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum bactericidal activity for Yersinia enterocolitica in hemodialysis patients: effects of iron overload and deferoxamine.
    Gaughan WJ; Beserab A; Stein HD; Sirota RA; Yudis M
    Am J Kidney Dis; 1992 Feb; 19(2):144-8. PubMed ID: 1739096
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Roles of iron overload and chelating treatment in Yersinia infectious complicated by major thalassemia].
    François P; Bachelot C; Andrini P; Bost M
    Presse Med; 1987 Oct; 16(32):1574-6. PubMed ID: 2958832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yersinia pseudotuberculosis septicaemia in thalassaemia major.
    Gordts B; Rummens E; deMeirleir L; Butzler JP
    Lancet; 1984 Jan; 1(8367):41-2. PubMed ID: 6140358
    [No Abstract]   [Full Text] [Related]  

  • 35. High-dose intravenous desferrioxamine (DFO) delivery in four thalassemic patients allergic to subcutaneous DFO administration.
    Lombardo T; Ferro G; Frontini V; Percolla S
    Am J Hematol; 1996 Jan; 51(1):90-2. PubMed ID: 8571945
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Fatal Yersinia enterocolitica septic shock in a child with chronic anemia].
    Dumont-Senaneuch C; Floret D; Philippe N
    Pediatrie; 1988; 43(6):519-20. PubMed ID: 3186423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Yersinia enterocolitica infection with ileal perforation associated with iron overload and deferoxamine therapy.
    Mazzoleni G; deSa D; Gately J; Riddell RH
    Dig Dis Sci; 1991 Aug; 36(8):1154-60. PubMed ID: 1864209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Yersinia hepatic abscesses and iron overload.
    Chiesa C; Pacifico L; Renzulli F; Midulla M; Garlaschi L
    JAMA; 1987 Jun; 257(23):3230-1. PubMed ID: 3586244
    [No Abstract]   [Full Text] [Related]  

  • 39. Mucormycosis infection in dialysis patients.
    Boelaert JR; Vergauwe PL; Vandepitte JM
    Ann Intern Med; 1987 Nov; 107(5):782-3. PubMed ID: 3662297
    [No Abstract]   [Full Text] [Related]  

  • 40. Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?
    Goodill JJ; Abuelo JG
    N Engl J Med; 1987 Jul; 317(1):54. PubMed ID: 3587314
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.